BML of the Knee for Bone Marrow Edema (SCP Trial)

N/A

Waitlist Available

Led By Steven Cohen, MD

Research Sponsored by Zimmer Biomet

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

No Placebo-Only Group

Summary

Studying long-term changes in a sub-set of patients who undergo the Subchondroplasty procedure including changes in pain, function, and overall health.

Eligible Conditions

Bone Marrow Edema

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Knee Injury Osteoarthritis Outcomes Score (KOOS) Pain Subscore

Secondary study objectives

Complications or secondary procedures at index site of knee

Improvement from baseline in KOOS subsection scores

Improvement in IKDC

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: BML of the KneeExperimental Treatment1 Intervention

Subject has single bone marrow lesion of tibia, single BML of femur, or adjoining BML's of tibia \& femur on which a Subchondroplasty procedure is performed

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Subchondroplasty

2012

N/A

~70

Do I qualify?Apply below to find out